• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    DBV Technologies S.A. - American Depositary Shares (NQ: DBVT )

    2.980 -0.060 (-1.97%)
    Streaming Delayed Price Updated: 3:09 PM EST, Dec 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 24,109
    Open 3.040
    Bid (Size) 2.950 (1)
    Ask (Size) 3.010 (1)
    Prev. Close 3.040
    Today's Range 2.925 - 3.050
    52wk Range 0.4409 - 4.500
    Shares Outstanding 55,096,537
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    DBV Aligns With FDA On Accelerated Approval For Viaskin Peanut Patch In Younger Kids
    DBV Technologies secures FDA guidance for Accelerated Approval of its Viaskin Peanut patch, advancing treatment for toddlers with peanut allergies through pivotal trials. 
    Via Benzinga
    Exposures Product Safety
    Wall Street Poised To Open Lower A Day After Nasdaq's Record Close Above 20,000: Expert Flags 'Deterioration Under The Surface' As 117 S&P 500 Stocks Hit New Monthly Lows
    U.S. stock futures declined on Thursday in premarket hours after hitting fresh highs on Wednesday. S&P 500, Dow, Nasdaq 100 & R2K were down. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities

    Performance

    YTD
    +57.29%
    +57.29%
    1 Month
    +496.00%
    +496.00%
    3 Month
    +325.71%
    +325.71%
    6 Month
    +217.02%
    +217.02%
    1 Year
    +57.02%
    +57.02%

    More News

    Read More
    Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old
    From DBV Technologies S.A.
    Via GlobeNewswire
    Information regarding the total number of voting rights and  total number of shares of the Company as of November 30, 2024
    From DBV Technologies S.A.
    Via GlobeNewswire
    DBV Technologies Announces Plan to Implement ADS Ratio Change
    From DBV Technologies S.A.
    Via GlobeNewswire
    DBV Technologies Reports Third Quarter 2024 Financial Results
    From DBV Technologies S.A.
    Via GlobeNewswire
    Tesla To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why Tesla Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX
    Via AB Newswire
    Topics Intellectual Property
    Exposures Intellectual Property
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Penny Stock DBV Technologies Advances Viaskin Peanut Allergy Patch With FDA Approval Pathway
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe
    From DBV Technologies S.A.
    Via GlobeNewswire
    DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
    From DBV Technologies S.A.
    Via GlobeNewswire
    Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024
    From DBV Technologies S.A.
    Via GlobeNewswire
    DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial
    From DBV Technologies S.A.
    Via GlobeNewswire
    DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
    From DBV Technologies S.A.
    Via GlobeNewswire
    Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024
    From DBV Technologies S.A.
    Via GlobeNewswire
    DBVT Stock Earnings: DBV Technologies Beats EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report
    From DBV Technologies S.A.
    Via GlobeNewswire
    DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results
    From DBV Technologies S.A.
    Via GlobeNewswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.